Modulation of inflammation by CD73-mediated adenosinergic signaling via specific adenosine receptor subtypes has been characterized in various murine models, including T cell–dependent autoimmune encephalomyelitis [15], colitis [16], [17], infections [18], and in anti-tumor T cell immunity [19]–[23]. This evidence concerns the gene NT5E and neoplasm.